UK Renal Registry 12th Annual Report (December 2009): Chapter 14 Demography of the UK Paediatric Renal Replacement Therapy population in 2008

被引:34
|
作者
Lewis, Malcolm A. [1 ,2 ]
Shaw, Joanne [2 ]
Sinha, Manish D. [3 ]
Adalat, Shazia [3 ]
Hussain, Farida [4 ]
Castledine, Clare
van Schalkwyk, Dirk
Inward, Carol [5 ]
机构
[1] Southmead Hosp, UK Renal Registry, Bristol BS10 5NB, Avon, England
[2] Royal Manchester Childrens Hosp, Manchester M27 1HA, Lancs, England
[3] Evelina Childrens Hosp, London, England
[4] Univ Nottingham Hosp, Nottingham NG7 2UH, England
[5] Bristol Royal Hosp Children, Bristol, Avon, England
来源
NEPHRON CLINICAL PRACTICE | 2010年 / 115卷
关键词
Aetiology; Children; Demography; End stage renal disease; Established renal failure; Incidence; Mortality; Prevalence; CHILDREN; DISEASE;
D O I
10.1159/000301237
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims: To describe the demographics of the paediatric RRT population in the UK and analyse changes in demographics with time. Methods: Extraction and analysis of data from the UK Paediatric Renal Registry and the UK Renal Registry (UKRR). Results: The UK paediatric established renal failure (ERF) population in December 2008 was 905 patients. The prevalence under the age of 16 years was 56 per million age related population (pmarp) and the incidence 7.4 pmarp. The incidence and prevalence for South Asian patients was much higher than that of the White and Black populations. Renal dysplasia was the most common cause of ERF accounting for 33% of prevalent cases. Diseases with autosomal recessive inheritance were a common cause of ERF in all ethnic groups, 23.5% of prevalent and 18% of incident cases. Whilst the incidence and prevalence of diseases with autosomal recessive inheritance in the South Asian population was 3 times that of the white population, this was not the sole reason for the increased proportion of South Asian patients with ERF, as diseases with no defined inheritance were twice as common in this ethnic group than in White patients. Prevalent mortality stood at 9.4%. Most deaths were in patients presenting with ERF early in life and mortality varied markedly according to the aetiology of ERF. The proportion with new grafts from living donors has steadily risen to 54%. Children from ethnic minority groups were less likely to have an allograft and living donation was less frequent in this population. For those on dialysis, 56% were receiving peritoneal dialysis. This was the main treatment modality for patients under 4 years of age. Conclusions: The paediatric ERF population continued to expand slowly. Incidence and prevalence rates were stable and similar to other developed nations. The high incidence in patients from ethnic minority groups will lead to a greater proportion of the population being from these groups in time. To maintain the high proportion of engrafted patients it will be necessary to encourage living donation in the ethnic minority population. Case note analysis of the factors involved in mortality would be valuable.
引用
收藏
页码:C279 / C288
页数:10
相关论文
共 50 条
  • [1] UK Renal Registry 13th Annual Report (December 2010): Chapter 5 Demography of the UK Paediatric Renal Replacement Therapy Population in 2009
    Sinha, Manish D.
    Castledine, Clare
    van Schalkwyk, Dirk
    Hussain, Farida
    Lewis, Malcolm
    Inward, Carol
    NEPHRON CLINICAL PRACTICE, 2011, 119 : C97 - C106
  • [2] UK Renal Registry 14th Annual Report: Chapter 5 Demography of the UK Paediatric Renal Replacement Therapy population in 2010
    Pruthi, Rishi
    Sinha, Manish D.
    Casula, Anna
    Tse, Yincent
    Maxwell, Heather
    O'Brien, Catherine
    Lewis, Malcolm
    Inward, Carol
    NEPHRON CLINICAL PRACTICE, 2012, 120 : C93 - C103
  • [3] UK Renal Registry 12th Annual Report (December 2009): Chapter 1 Summary of findings in the 2009 UK Renal Registry Report
    Tomson, Charles R. V.
    NEPHRON CLINICAL PRACTICE, 2010, 115 : C1 - C2
  • [4] UK Renal Registry 20th Annual Report Chapter 4 Demography of the UK Paediatric Renal Replacement Therapy Population in 2016
    Plumb, Lucy
    Wong, Esther
    Casula, Anna
    Braddon, Fiona
    Lewis, Malcolm
    Marks, Stephen D.
    Shenoy, Mohan
    Sinha, Manish D.
    Maxwell, Heather
    NEPHRON, 2018, 139 : 105 - 116
  • [5] UK Renal Registry 19th Annual Report: Chapter 4 Demography of the UK Paediatric Renal Replacement Therapy Population in 2015
    Hamilton, Alexander J.
    Braddon, Fiona
    Casula, Anna
    Lewis, Malcolm
    Mallett, Tamara
    Marks, Stephen D.
    Shenoy, Mohan
    Sinha, Manish D.
    Tse, Yincent
    Maxwell, Heather
    NEPHRON, 2017, 137 : 103 - 115
  • [6] UK Renal Registry 16th Annual Report: Chapter 7 Demography of the UK Paediatric Renal Replacement Therapy population in 2012
    Pruthi, Rishi
    O'Brien, Catherine
    Casula, Anna
    Braddon, Fiona
    Lewis, Malcolm
    Maxwell, Heather
    Stojanovic, Jelena
    Tse, Yincent
    Inward, Carol
    Sinha, Manish D.
    NEPHRON CLINICAL PRACTICE, 2013, 125 (1-4): : 127 - 138
  • [7] UK Renal Registry 15th Annual Report: Chapter 4 Demography of the UK Paediatric Renal Replacement Therapy Population in 2011
    Pruthi, Rishi
    O'Brien, Catherine
    Casula, Anna
    Braddon, Fiona
    Lewis, Malcolm
    Maxwell, Heather
    Tse, Yincent
    Inward, Carol
    Sinha, Manish D.
    NEPHRON CLINICAL PRACTICE, 2013, 123 : 81 - 92
  • [8] UK Renal Registry 12th Annual Report (December 2009): Chapter 2 Introduction
    Tomson, Charles R. V.
    Maggs, Christopher
    NEPHRON CLINICAL PRACTICE, 2010, 115 : C3 - C8
  • [9] UK Renal Registry 17th Annual Report: Chapter 4 Demography of the UK Paediatric Renal Replacement Therapy Population in 2013
    Pruthi, Rishi
    Hamilton, Alexander J.
    O'Brien, Catherine
    Casula, Anna
    Braddon, Fiona
    Inward, Carol
    Lewis, Malcolm
    Maxwell, Heather
    Stojanovic, Jelena
    Tse, Yincent
    Sinha, Manish D.
    NEPHRON, 2015, 129 : 87 - 98
  • [10] UK Renal Registry 12th Annual Report (December 2009): Appendix A The UK Renal Registry Statement of Purpose
    不详
    NEPHRON CLINICAL PRACTICE, 2010, 115 : C321 - C326